Results 181 to 190 of about 2,458 (200)

Cotrimoxazole/duvelisib

Reactions Weekly, 2022
openaire   +1 more source

Copanlisib/dexamethasone/duvelisib

Reactions Weekly, 2021
openaire   +1 more source

Nouvelle AMM : duvelisib – LLC et lymphome folliculaire en rechute ou réfractaire

Bulletin du Cancer, 2021
Léa Fornero, Sylvain Lamure
openaire   +1 more source

Duvelisib increases risk of serious AEs and death

Reactions Weekly, 2022
openaire   +1 more source

Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia

British Journal of Haematology, 2022
Shira R. Paul, Douglas R. Rosing, Mark C. Haigney, Cody J. Peer, William D. Figg, Adrian Wiestner, Clare Sun   +6 more
openaire   +2 more sources

Duvelisib

Reactions Weekly
openaire   +2 more sources

Duvelisib (Copiktra®)

Oncology Times, 2019
openaire   +1 more source

Duvelisib in haematological malignancies

The Lancet Oncology, 2018
openaire   +1 more source

Duvelisib in indolent non-Hodgkin lymphoma

The Lancet Oncology, 2019
openaire   +2 more sources

[New European approval: Duvelisib - relapsed/refractory CLL and follicular lymphoma].

Bulletin du cancer, 2022
Léa, Fornero, Sylvain, Lamure
openaire   +1 more source